NIAID Banner Logo Image

HIV Citation List: June 24 - July 7, 2009

Pubmed citations:

1. Synthesis, antiviral activity and molecular modeling of oxoquinoline derivatives. Santos FD, Abreu P, Castro HC, Paixão IC, Cirne-Santos CC, Giongo V, Barbosa JE, Simonetti BR, Garrido V, Bou-Habib DC, Silva DD, Batalha PN, Temerozo JR, Souza TM, Nogueira CM, Cunha AC, Rodrigues CR, Ferreira VF, de Souza MC. Bioorg Med Chem. 2009 Jun 24. [Epub ahead of print] PMID: 19581097

2. Multivalent Manno-Glyconanoparticles Inhibit DC-SIGN-Mediated HIV-1 Trans-Infection of Human T Cells.Martínez-Ávila O, Bedoya LM, Marradi M, Clavel C, Alcamí J, Penadés S. Chembiochem. 2009 Jun 29. [Epub ahead of print] No abstract available. PMID: 19565596

3. CD4-BFFI: A Novel, Bifunctional HIV-1 Entry Inhibitor with High and Broad Anti-HIV-1 Potency. Jekle A, Chow E, Kopetzki E, Ji C, Yan MJ, Nguyen R, Sankuratri S, Cammack N, Heilek G. Antiviral Res. 2009 Jun 24. [Epub ahead of print] PMID: 19559732

4. IL-27 inhibition of HIV-1 involves an intermediate induction of type I IFN. Greenwell-Wild T, Vazquez N, Jin W, Rangel Z, Munson P, Wahl SM. Blood. 2009 Jun 25. [Epub ahead of print] PMID: 19556424

5. Concise and Versatile Multicomponent Synthesis of Multisubstituted Polyfunctional Dihydropyrroles. Zhu Q, Jiang H, Li J, Liu S, Xia C, Zhang M. J Comb Chem. 2009 Jun 24. [Epub ahead of print] PMID: 19552380

6. Epigenetic regulation of HIV-1 latency by cytosine methylation. Kauder SE, Bosque A, Lindqvist A, Planelles V, Verdin E. PLoS Pathog. 2009 Jun;5(6):e1000495. Epub 2009 Jun 26. PMID: 19557157

7. Rilpivirine: a novel non-nucleoside reverse transcriptase inhibitor. Garvey L, Winston A. Expert Opin Investig Drugs. 2009 Jul;18(7):1035-41. PMID: 19548857

8. CCL20/MIP3alpha is a novel anti-HIV-1 molecule of the human female reproductive tract. Ghosh M, Shen Z, Schaefer TM, Fahey JV, Gupta P, Wira CR. Am J Reprod Immunol. 2009 Jul;62(1):60-71. PMID: 19527233

9. Cytotoxicological analysis of a gp120 binding aptamer with cross-clade human immunodeficiency virus type 1 entry inhibition properties: comparison to conventional antiretrovirals. Lopes de Campos WR, Coopusamy D, Morris L, Mayosi BM, Khati M. Antimicrob Agents Chemother. 2009 Jul;53(7):3056-64. Epub 2009 Apr 13. PMID: 19364860

ISI Web of Science citations:

10. GSH and analogs in antiviral therapy. Fraternale, A; Paoletti, MF; Casabianca, A; Nencioni, L; Garaci, E; Palamara, AT; Magnani, M. MOLECULAR ASPECTS OF MEDICINE, 2009; 30(1-2): 99-110.

11. SYNTHESIS AND BIOLOGICAL EVALUATION OF NOVEL SUBSTITUTEDN1-[1-BENZYL-3-(3-TERT-BUTYLCARBAMOYL-OCTAHYDROISOQUINOLIN-2Y L)-2-HYDROXY-PROPYL]-2-[(2-OXO-2H-CHROMENE-3-CARBONYL)AMINO] SUCCINAMIDE ANALOGS AS ANTI-VIRAL AND ANTI-HIV AGENTS. Reddy, YT; Reddy, PN; Crooks, PA; De Clercq, E; Rao, GVP; Rajitha, B. HETEROCYCLIC COMMUNICATIONS, 2008; 14(6): 419-426.

12. Characterization of HIV-1 Enzyme Reverse Transcriptase Inhibition by the Compound 6-Chloro-1,4-Dihydro-4-Oxo-1-(beta-D-Ribofuranosyl) Quinoline-3-Carboxylic Acid Through Kinetic and In Silico Studies. Souza, TML; Rodrigues, DQ; Ferreira, VF; Marques, IP; Santos, FD; Cunha, AC; de Souza, MCBV; Frugulhetti, ICDP; Bou-Habib, DC; Fontes, CFL. CURRENT HIV RESEARCH, 2009; 7(3): 327-335.

If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: September 2024